What it sells
We are developing a drug to burn calories and increase metabolism…
Business model breakdown
Buyer: who owns the budget?
UnverifiedProspective pharma licensing/partnering counterparts.
Workflow: what inputs become what output?
Measure mitochondrial electrical currents to identify heat-generating proteins, screen compounds with proprietary high-throughput assays, and pick selective, safe thermogenic activators.
Economics: what it saves and how it charges
UnverifiedPreclinical drug developer; no revenue stated; value comes from advancing a first-in-class drug, likely via partnering or licensing.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2020 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.